Effect of exercise on neuromuscular toxicity in oxaliplatin‐treated mice. Issue 2 (12th June 2021)

• Record Type: Journal Article
• Authors: Lees, Justin G.; Abdulla, Munawwar; Barkl‐Luke, Mallory E.; Livni, Lital; Keating, Brooke A.; Hayes, Jessica; Fiore, Nathan T.; Park, Susanna B.; Moalem‐Taylor, Gila; Goldstein, David
• Is Part Of: Muscle & nerve. Volume 64:Issue 2(2021)
• Page Start: 225
• Page End: 234
• Publication Date: 2021-06-12
• Subjects: exercise -- muscle wasting -- neuromuscular -- oxaliplatin -- peripheral neuropathy; Neuromuscular diseases -- Periodicals; Muscles -- Periodicals; Nerves -- Periodicals; 616.74
• DOI: 10.1002/mus.27329
• Languages: English
• ISSNs: 0148-639X

Abstract

Abstract: Introduction/Aims: Clinically, the chemotherapeutic agent oxaliplatin can cause peripheral neuropathy, impaired balance, and muscle wastage. Using a preclinical model, we investigated whether exercise intervention could improve these adverse conditions. Methods: Mice were chronically treated with oxaliplatin alone or in conjunction with exercise. Behavioral studies, including mechanical allodynia, rotarod, open‐field, and grip‐strength tests, were performed. After euthanasia, multiple organs and four different muscle types were dissected and weighed. The cross‐sectional area (CSA) of muscle fibers in the gastrocnemius muscle was assessed and gene expression analysis performed on the forelimb triceps muscle. Results: Oxaliplatin‐treated mice displayed reduced weight gain, mechanical allodynia, and exploratory behavior deficits that were not significantly improved by exercise. Oxaliplatin‐treated exercised mice showed modest evidence of reduced muscle wastage compared with mice treated with oxaliplatin alone, and exercised mice demonstrated evidence of a mild increase in CSA of muscle fibers. Discussion: Exercise intervention did not improve signs of peripheral neuropathy but moderately reduced the negative impact of oxaliplatin chemotherapy related to muscle morphology, suggesting the potential for exploring the impact of exercise on reducing oxaliplatin‐induced neuromuscular toxicity in cancer patients.